0001209191-12-007595.txt : 20120203
0001209191-12-007595.hdr.sgml : 20120203
20120203175445
ACCESSION NUMBER: 0001209191-12-007595
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120201
FILED AS OF DATE: 20120203
DATE AS OF CHANGE: 20120203
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ONYX PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001012140
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 943154463
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 249 E. GRAND AVE.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-266-0000
MAIL ADDRESS:
STREET 1: 249 E. GRAND AVE.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WIERENGA WENDALL
CENTRAL INDEX KEY: 0001235945
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-28298
FILM NUMBER: 12571424
MAIL ADDRESS:
STREET 1: 12790 EL CAMINO REAL
STREET 2: C/O NEUROCRINE BIOSCIENCES
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER NAME:
FORMER CONFORMED NAME: WIERENGA WENDALL D
DATE OF NAME CHANGE: 20030527
4
1
doc4.xml
FORM 4 SUBMISSION
X0304
4
2012-02-01
0
0001012140
ONYX PHARMACEUTICALS INC
ONXX
0001235945
WIERENGA WENDALL
C/O ONYX PHARMACEUTICALS, INC.
249 EAST GRAND AVE.
SOUTH SAN FRANCISCO
CA
94080
1
0
0
0
Common Stock
2012-02-01
4
S
0
250
41.38
D
5580
D
Shares sold pursuant to a 10b5-1 plan.
/s/ Warren DeSouza, Attorney-in-fact
2012-02-03